Prognostic Value of IgM in Covid-19 Infection
NCT05092594 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2022-04-12
Summary
The primary objective of the research is to study the relation between the presence and /or the anti SARS-Co-V-2 IgM level in an early stage of COVID-19 infection, and the evolution of the illness.
Conditions
Sponsors & Collaborators
-
Assistance Publique - Hôpitaux de Paris
lead OTHER
Principal Investigators
-
Jean-Louis Gaillard, MD, PhD · Microbiological Laboratory - CHU Ambroise Paré - APHP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-04-30
- Primary Completion
- 2022-05-31
- Completion
- 2022-05-31
More Related Trials
-
Description of Immunologic, Enzymatic and Metabolic Biomarkers Associated to the Severity of COVID-19 (SARS-CoV-2) and Its Resolution
NCT04664023 ·Status: COMPLETED
-
CoViD-19 Patient in Reims University Hospital in March to April 2020
NCT04553575 ·Status: COMPLETED
-
COVID-19 Prevalence in UNIVI Geriatric Institutions: Epidemiological Study of Immunological Status With Rapid Serological Tests
NCT04790994 ·Status: UNKNOWN
-
A Prospective Virtual Study to Evaluate the Longevity of IgG Antibodies in Individuals Exposed to COVID-19
NCT05042193 ·Status: COMPLETED
-
Covid-19 Convalescent Plasma and Monoclonal Antibodies Treatment of Immunocompromised Patients
NCT05905380 ·Status: UNKNOWN
-
Immune Responses to COVID-19; Isolation of Neutralizing Antibodies for Therapeutics and Vaccine.
NCT04596098 ·Status: COMPLETED
-
Study of the Incidence of SARS-CoV-2 Infection (COVID-19)
NCT04429594 ·Status: RECRUITING ·Phase: NA
-
Containment Impact on Primary Care & Adverse Events Unrelated to COVID-19 in Older Patients and/or With Chronic Diseases
NCT04907994 ·Status: UNKNOWN
-
COVID-19 in PID Survey
NCT04459689 ·Status: RECRUITING
-
In Utero Exposure to SARS-CoV-2 (COVID-19) and Cardiovascular and Metabolic Endpoints in Early Life
NCT04921241 ·Status: COMPLETED
-
Maternal-foetal Transmission of SARS-Cov-2
NCT04395924 ·Status: COMPLETED
-
Study of the Kinetics of COVID-19 Antibodies for 24 Months in Patients With Confirmed SARS-CoV-2 Infection
NCT04750720 ·Status: COMPLETED ·Phase: NA
-
Prevalence and Impact of COVID-19 Infection in Pregnant Women, Fetuses and Newborns
NCT04355234 ·Status: COMPLETED ·Phase: NA
-
Immunogenicity Against SARS-CoV-2 in COVID-19 Close Contacts
NCT05094635 ·Status: UNKNOWN
-
Correlation Study of Isotype Switching and Neutralizing Capacity to the COVID-19 Variants Strain
NCT05087277 ·Status: UNKNOWN
-
Evaluation of COVID-19 Immune Barrier and Reinfection Risk
NCT05774093 ·Status: RECRUITING
-
Prospective Clinical and Virological Analysis of Healthcare Workers Diagnosed Positive for Covid-19.
NCT04858581 ·Status: UNKNOWN ·Phase: NA
-
Immunoglobulin G Antibody Immune Response Profile Following Infection With SARS-CoV-2 in COVID-19 Egyptian Patients
NCT04483622 ·Status: COMPLETED
-
Creation of a Biotheque of Patients of Seine-Maritime With Meningococcal Infection
NCT00450632 ·Status: COMPLETED
-
Prognostic Factors in Patients Admitted to an Urban Teaching Hospital With COVID-19 Infection
NCT04484545 ·Status: UNKNOWN
-
COVID-19 Pregnancy Related Immunological, Clinical and Epidemiological Factors and Perinatal Outcomes
NCT04659759 ·Status: COMPLETED
-
Immune Response and Cytomegalovirus in Intensive Care Unit (ICU) Patients
NCT00699868 ·Status: COMPLETED ·Phase: NA
-
RT-PCR on Conjunctival Sample for the Detection of SARS-CoV-2 in Patients With Covid-19
NCT04397666 ·Status: UNKNOWN ·Phase: NA
-
Neutralizing Power of Anti-SARS-CoV-2 (Anti-COVID-19) Serum Antibodies
NCT05315583 ·Status: TERMINATED ·Phase: NA
-
Evaluation of the Safety and Efficacy of Standard Intravenous Immunoglobulins in Pregnant Women With Primary Cytomegalovirus Infection
NCT01659684 ·Status: UNKNOWN ·Phase: NA